Vitamin D Synthesis
Vitamin D synthesis is a unique physiological process in which the skin functions as an endocrine organ. Through UVB-driven photochemical reactions, the epidermis produces the precursor molecule that ultimately becomes biologically active vitamin D₃ (calcitriol). This hormone plays a crucial role in calcium homeostasis, bone mineralisation, immune regulation and cellular differentiation. The cutaneous phase of vitamin D synthesis provides insight into how sunlight, pigmentation, aging, sunscreen use and environmental factors influence overall vitamin D status.
What You Need to Know
Vitamin D synthesis is a unique physiological process that begins in the skin and links environmental exposure with endocrine regulation. When skin is exposed to ultraviolet B (UVB) radiation, 7-dehydrocholesterol in the epidermis is converted to previtamin D₃, which then undergoes thermal isomerisation to form vitamin D₃ (cholecalciferol). This cutaneous production is the primary source of vitamin D for most individuals.
Several factors influence how effectively the skin can synthesise vitamin D:
Intensity and duration of UVB exposure
Skin pigmentation and thickness
Age-related changes in epidermal composition
Geographic location, season, clothing, and sunscreen use
Once formed, vitamin D₃ enters the circulation and undergoes two sequential hydroxylation steps to become biologically active. The first occurs in the liver, producing 25-hydroxyvitamin D, the main circulating form used to assess vitamin D status. The second occurs in the kidney, where 1-alpha hydroxylase converts it into calcitriol, the active hormone. Calcitriol plays a central role in calcium and phosphate homeostasis, bone health, and neuromuscular function. Because synthesis depends on both skin exposure and organ function, disruptions at any stage can lead to deficiency and wide-ranging physiological consequences.
Beyond the Basics
Epidermal origin of vitamin D synthesis
Vitamin D synthesis begins within the epidermis, where the precursor molecule 7-dehydrocholesterol is highly concentrated in the stratum basale and stratum spinosum. These layers are ideally positioned to absorb ultraviolet B radiation within the wavelength range of approximately 290 to 315 nanometres. When UVB photons penetrate the epidermis, they break a specific bond within the 7-dehydrocholesterol molecule, forming previtamin D₃. This compound is thermodynamically unstable and gradually rearranges into vitamin D₃ through a process of thermal isomerisation over several hours.
This cutaneous step is entirely non-enzymatic and depends on adequate UVB exposure reaching viable epidermal layers. Because UVB penetration is limited to superficial skin, anything that reduces photon delivery to these layers directly limits vitamin D production. This initial step therefore represents a critical interface between environmental exposure and endocrine physiology.
Transport and hepatic conversion
Once formed in the skin, vitamin D₃ enters the circulation bound to vitamin D binding protein, which facilitates its transport to the liver. In hepatocytes, vitamin D₃ undergoes its first hydroxylation via the enzyme 25-hydroxylase, producing 25-hydroxyvitamin D. This metabolite is the major circulating form of vitamin D and reflects the body’s overall vitamin D reserve.
Although biologically inactive, 25-hydroxyvitamin D has a relatively long half-life, making it the preferred marker for assessing vitamin D status clinically. At this stage, vitamin D is still hormonally inactive and requires further modification before it can exert physiological effects.
Renal activation and hormonal regulation
The second and decisive activation step occurs in the proximal tubules of the kidney. Here, the enzyme 1-alpha hydroxylase converts 25-hydroxyvitamin D into 1,25-dihydroxyvitamin D, also known as calcitriol. Calcitriol functions as a steroid hormone and exerts effects on multiple target tissues.
Renal activation is tightly regulated to prevent disturbances in calcium and phosphate balance. Parathyroid hormone stimulates calcitriol production when serum calcium levels fall, while elevated calcium or phosphate levels suppress activation. Fibroblast growth factor 23 also plays an inhibitory role, preventing excessive calcitriol formation and protecting against hypercalcaemia. This regulatory network ensures that vitamin D activation is closely matched to physiological demand.
Systemic actions of calcitriol
Calcitriol plays a central role in maintaining calcium and phosphate homeostasis. In the intestine, it increases expression of calcium-binding proteins within enterocytes, enhancing absorption of dietary calcium and phosphate. In the kidneys, it supports calcium reabsorption in the distal tubules, reducing urinary loss and conserving mineral stores.
Within bone, calcitriol ensures adequate mineral availability for normal bone formation and remodelling. When calcium intake or availability is insufficient, calcitriol acts in concert with parathyroid hormone to increase osteoclastic activity indirectly, mobilising calcium from skeletal stores to maintain serum levels. Beyond mineral metabolism, calcitriol also influences immune regulation, antimicrobial peptide production, and keratinocyte proliferation and differentiation, highlighting its broader role in integumentary and immune health.
Factors influencing cutaneous synthesis
The efficiency of cutaneous vitamin D synthesis varies widely between individuals and environments. Melanin within the epidermis competes with 7-dehydrocholesterol for UVB photons, meaning individuals with darker skin require longer or more intense exposure to generate equivalent amounts of vitamin D₃. Ageing further reduces synthesis because epidermal concentrations of 7-dehydrocholesterol decline over time.
Geographic latitude and season also play a significant role, as UVB intensity decreases with distance from the equator and during winter months. In higher latitudes, vitamin D synthesis may be negligible for extended periods each year. Sunscreen use and clothing coverage reduce UVB penetration when applied effectively, while standard window glass blocks nearly all UVB radiation, rendering indoor sunlight exposure ineffective for vitamin D production.
Natural protection against excess
The skin possesses intrinsic mechanisms that prevent vitamin D toxicity from sun exposure. When UVB exposure is prolonged, excess previtamin D₃ and vitamin D₃ are converted into biologically inactive photoproducts such as lumisterol and tachysterol. This self-limiting process ensures that excessive sun exposure does not result in vitamin D overdose.
While this mechanism protects against hypervitaminosis D, it does not protect against other consequences of excessive UV exposure. Photoaging and skin cancer risk continue to increase with cumulative ultraviolet exposure, underscoring the need to balance vitamin D synthesis with skin protection.
Clinical Connections
Disorders of vitamin D balance have wide-ranging clinical effects because calcitriol influences bone metabolism, muscle function, immune regulation, and calcium homeostasis. Deficiency often develops gradually and may present with nonspecific symptoms before overt skeletal disease becomes apparent, particularly in populations with limited cutaneous synthesis or impaired activation.
In clinical practice, vitamin D–related problems most commonly present through the following patterns:
Impaired bone mineralisation and increased fracture risk
Muscle weakness and reduced physical function
Altered immune and inflammatory responses
Vitamin D deficiency in adults leads to osteomalacia, characterised by defective bone mineralisation, bone pain, and increased fracture risk, while deficiency during growth causes rickets in children. Reduced calcitriol activity also contributes to proximal muscle weakness, impaired balance, and falls, particularly in older adults. Immune effects include increased susceptibility to infection and altered inflammatory responses, reflecting vitamin D’s role in immune modulation.
Certain populations are at higher risk of deficiency due to reduced synthesis or absorption. Older adults have diminished cutaneous production, individuals with darker skin require greater UVB exposure for equivalent synthesis, and people living at high latitudes may experience prolonged periods of inadequate UVB exposure. Deficiency is also common in those who avoid sun exposure, wear extensive covering, or have malabsorption syndromes affecting fat-soluble vitamin uptake.
Excess calcitriol, though less common, may occur in granulomatous diseases, certain malignancies, or with excessive supplementation, leading to hypercalcaemia and associated systemic effects. Interpreting calcium levels alongside vitamin D metabolites is therefore essential for safe and effective management.
Concept Check
What are the key steps in converting 7-dehydrocholesterol into active vitamin D?
Why is 25-hydroxyvitamin D used as a clinical measure of vitamin D status?
How does calcitriol regulate calcium homeostasis?
What factors reduce the skin’s ability to synthesise vitamin D?
Why does prolonged sun exposure not lead to vitamin D toxicity?